Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas

In this study, we developed a method to improve the delineation of intrinsic brain tumors based on the changes in metabolism due to tumor infiltration. Proton magnetic resonance spectroscopic imaging ((1)H-MRSI) with a nominal voxel size of 0.45 cm(3) was used to investigate the spatial distribution of choline-containing compounds (Cho), creatine (Cr) and N-acetyl-aspartate (NAA) in brain tumors and normal brain. Ten patients with untreated gliomas were examined on a 1.5 T clinical scanner using a MRSI sequence with PRESS volume preselection. Metabolic maps of Cho, Cr, NAA and Cho/NAA ratios were calculated. Tumors were automatically segmented in the Cho/NAA images based on the assumption of Gaussian distribution of Cho/NAA values in normal brain using a limit for normal brain tissue of the mean + three times the standard deviation. Based on this threshold, an area was calculated which was delineated as pathologic tissue. This area was then compared to areas of hyperintense signal caused by the tumor in T2-weighted MRI, which were determined by a region growing algorithm in combination with visual inspection by two experienced clinicians. The area that was abnormal on (1)H-MRSI exceeded the area delineated via T2 signal changes in the tumor (mean difference 24%) in all cases. For verification of higher sensitivity of our spectroscopic imaging strategy we developed a method for coregistration of MRI and MRSI data sets. Integration of the biochemical information into a frameless stereotactic system allowed biopsy sampling from the brain areas that showed normal T2-weighted signal but abnormal (1)H-MRSI changes. The histological findings showed tumor infiltration ranging from about 4-17% in areas differentiated from normal tissue by (1)H-MRSI only. We conclude that high spatial resolution (1)H-MRSI (nominal voxel size = 0.45 cm(3)) in combination with our segmentation algorithm can improve delineation of tumor borders compared to routine MRI tumor diagnosis.

[1]  J Hennig,et al.  Human brain tumors: assessment with in vivo proton MR spectroscopy. , 1993, Radiology.

[2]  Edward E Graves,et al.  Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. , 2002, International journal of radiation oncology, biology, physics.

[3]  P R Luyten,et al.  Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. , 1990, Radiology.

[4]  Christopher Nimsky,et al.  Integration of biochemical images of a tumor into frameless stereotaxy achieved using a magnetic resonance imaging/magnetic resonance spectroscopy hybrid data set. , 2004, Journal of neurosurgery.

[5]  H. A. David,et al.  THE DISTRIBUTION OF THE RATIO, IN A SINGLE NORMAL SAMPLE, OF RANGE TO STANDARD DEVIATION , 1954 .

[6]  B Vikhoff-Baaz,et al.  Effects of k-space filtering and image interpolation on image fidelity in (1)H MRSI. , 2001, Magnetic resonance imaging.

[7]  Sylvie Grand,et al.  A new approach for analyzing proton magnetic resonance spectroscopic images of brain tumors: nosologic images , 2000, Nature Medicine.

[8]  Ying Lu,et al.  Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients , 2002, Journal of magnetic resonance imaging : JMRI.

[9]  D. Louis Collins,et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.

[10]  Carles Arús,et al.  Adult primitive neuroectodermal tumor: proton MR spectroscopic findings with possible application for differential diagnosis. , 2002, Radiology.

[11]  G. Kemp,et al.  Non-Invasive Methods for Studying Brain Energy Metabolism: What They Show and What It Means , 2000, Developmental Neuroscience.

[12]  R Steinmeier,et al.  Factors Influencing the Application Accuracy of Neuronavigation Systems , 2002, Stereotactic and Functional Neurosurgery.

[13]  D. Vigneron,et al.  An automated technique for the quantitative assessment of 3D‐MRSI data from patients with glioma , 2001, Journal of magnetic resonance imaging : JMRI.

[14]  L D Lunsford,et al.  Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. , 1993, Journal of neurosurgery.

[15]  J. Frahm,et al.  Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences. , 1991, Journal of computer assisted tomography.

[16]  M P Carol,et al.  MR-spectroscopy guided target delineation for high-grade gliomas. , 2001, International journal of radiation oncology, biology, physics.

[17]  Ewald Moser,et al.  High‐resolution 3D proton spectroscopic imaging of the human brain at 3 T: SNR issues and application for anatomy‐matched voxel sizes , 2003, Magnetic resonance in medicine.

[18]  W P Dillon,et al.  Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. , 2001, AJNR. American journal of neuroradiology.

[19]  T R Brown,et al.  Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. , 1996, Journal of neurosurgery.

[20]  M A Jacobs,et al.  Quantitative proton MR spectroscopic imaging of normal human cerebellum and brain stem , 2001, Magnetic resonance in medicine.

[21]  B. Miller.  A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.

[22]  R. L. Kamman,et al.  Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography , 1995, Neuroradiology.

[23]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  Chae-Yong Kim,et al.  Correlation of Clinical and Biological Parameters with Peritumoral Edema in Meningioma , 2002, Journal of Neuro-Oncology.

[25]  Irina Mader,et al.  Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors , 1996, Magnetic Resonance Materials in Physics, Biology and Medicine.

[26]  G. Sutherland,et al.  High‐Resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms , 1992, Magnetic resonance in medicine.

[27]  Daniel B Vigneron,et al.  In vivo molecular imaging for planning radiation therapy of gliomas: An application of 1H MRSI , 2002, Journal of magnetic resonance imaging : JMRI.

[28]  J. Frahm,et al.  Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. , 1993, Radiology.

[29]  G Tedeschi,et al.  Proton MR Spectroscopic Imaging without Water Suppression 1 To improve reproducibility in proton magnetic resonance , 2000 .

[30]  Oliver Ganslandt,et al.  A combined study of tumor-related brain lesions using MEG and proton MR spectroscopic imaging , 2001, Journal of the Neurological Sciences.

[31]  T. Mikkelsen,et al.  Correlation between Magnetic Resonance Spectroscopy Imaging and Image-guided Biopsies: Semiquantitative and Qualitative Histopathological Analyses of Patients with Untreated Glioma , 2001, Neurosurgery.

[32]  J A Frank,et al.  Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.